T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...
Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...
The following is a summary of “Role of T cell metabolism in brain tumor development: a genetic and metabolic approach,” ...
Vaccines that generate high levels of antibodies do not necessarily generate high levels of T cells. Development of vaccines must incorporate the viral components that T cells recognise and react ...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Vaccines that generate high levels of antibodies do not necessarily generate high levels of T cells. Development of vaccines must incorporate the viral components that T cells recognise and react ...
A collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging ...
As interest in immunotherapy grows, so does the need for better tools to engineer CAR T cells. Could advances in CRISPR technology be the solution? In the last decade, a new immunotherapy tool has ...
Historically, vaccine development has prioritised generating elevated levels of antibodies. This approach may not only limit the efficacy of vaccines but could also hinder our ability to combat ...
Findings challenge the longstanding reliance on neutralising antibodies for assessing viral immunity, and suggest that development of future vaccines must consider both antibody and T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback